A non-compartmental pharmacokinetic analysis was performed using Abbottbase Pharmacokinetic Systems™ (Abbott Laboratories, Illinois, USA). The maximum and trough plasma concentrations (C max and C min , respectively) were estimated directly from concentration-time data. The area under the plasma concentration-time curve over the 24-h dosing interval (AUC 0-24 ) was estimated using the linear trapezoidal rule for both prefilter and post-filter data. Clearance (CL) was estimated as dose/AUC 0-24. The apparent volume of distribution at steady state (V ss ) was estimated as the product of CL and mean residence time (MRT).
C max and C min were 13.5 and 2.19 mg/L, respectively (Fig. 1) . Pre-filter and post-filter AUC 0-24 were 107 and 111 mg/h/L, respectively; V ss was 18.9 L; CL was 0.933 L/h. Urine anidulafungin concentrations were negligible. All pharmacokinetic data were comparable to published data in critically ill patients with and without other types of extracorporeal support [5] .
Regarding the use of anti-infective drugs in patients on ECMO, most pharmacokinetic data on this topic are from neonatal studies of antibiotics [4] . To the best of our knowledge, this report is the first on the pharmacokinetics of anidulafungin in a critically ill patient on ECMO. In our case, the therapy had little effect on the pharmacokinetics, suggesting that the dose of anidulafungin does not need adjustment. However, future studies are needed to confirm these findings. 
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